GENETIC CHARACTERISTICS AND PREGNANCY OUTCOMES IN HIGH-RISK NIPT CASES FOR ANEUPLOIDIES OTHER THAN TRISOMY 13, 18, AND 21 AT THE UNIVERSITY MEDICAL CENTER, HO CHI MINH CITY

Từ Lê Khanh Huỳnh, Nhật Thăng Trần, Hùng Cường Phạm, Trung Đức Nguyễn, Thành Đạt Quan

Main Article Content

Abstract

NIPT) has been increasingly applied in obstetric practice due to its high sensitivity and specificity for detecting common aneuploidies (trisomy 13, 18, and 21). However, evidence regarding its predictive value and pregnancy outcomes for rare autosomal aneuploidies (RAAs) and sex chromosome aneuploidies (SCAs) remains limited, particularly in Vietnam. Describing genetic characteristics and pregnancy outcomes in this group is essential to support genetic counseling and clinical management. Objective: To describe the genetic characteristics and pregnancy outcomes in cases with high-risk NIPT results for aneuploidies other than trisomy 13, 18, and 21 at the University Medical Center, Ho Chi Minh City. Methods: A retrospective case series study was conducted on 44 pregnant women with high-risk NIPT results for non-T13/18/21 aneuploidies, who received counseling and/or follow-up at the Prenatal Diagnosis Unit, University Medical Center, Ho Chi Minh City, from July 2021 to June 2024. Data collected included sociodemographic characteristics, clinical history, invasive diagnostic results (amniocentesis, chorionic villus sampling), postnatal karyotype, ultrasound findings, and pregnancy outcomes. After delivery, developmental screening of children was performed using the Ten Questions Screening Instrument (TQSI). Results: Among 44 eligible cases, 25 women (56.8%) underwent invasive testing (24 amniocenteses, 1 chorionic villus sampling). Chromosomal abnormalities were confirmed in 12 cases (48.0%), while 13 cases (52.0%) showed normal karyotypes. The detection rate of chromosomal abnormalities was 42.9% in RAAs and 55.6% in SCAs. Regarding pregnancy outcomes, 77.3% continued to live birth, 6.8% resulted in stillbirth or termination, and 15.9% were lost to follow-up. A total of 34 liveborn children were evaluated postnatally, of whom 8.8% were identified with neurodevelopmental abnormalities using TQSI. Conclusions: High-risk NIPT results for rare aneuploidies present significant challenges in prenatal counseling and management due to the limited concordance with invasive diagnostic testing. This study contributes practical evidence from Vietnam on the genetic features and pregnancy outcomes of pregnancies with high-risk NIPT for RAAs and SCAs, highlighting the importance of confirmatory invasive testing and long-term developmental follow-up.

Article Details

References

1. Yang S, Zhuang Y, Li J, Fu X. Expanded non-invasive prenatal testing offers better detection of fetal copy number variations but not chromosomal aneuploidies. PLoS One. 2025 Jan 24; 20(1): e0312184. doi: 10.1371/journal.pone. 0312184.
2. Ge, Y., Li, J., Zhuang, J. et al. Expanded noninvasive prenatal testing for fetal aneuploidy and copy number variations and parental willingness for invasive diagnosis in a cohort of 18,516 cases. BMC Med Genomics. 2021 Apr 14;106. doi: 10.1186/s12920-021-00955-6.
3. Zou Y, Feng C, Qin J, Wang X, Huang T, Yang Y et al. Performance of expanded non-invasive prenatal testing for fetal aneuploidies and copy number variations: A prospective study from a single center in Jiangxi province, China. Front. Genet. Jan 2023;13:1073851. doi: 10.3389/fgene. 2022.1073851
4. Harasim T, Neuhann T, Behnecke A, Stampfer M, Holinski-Feder E, Abicht A. Initial Clinical Experience with NIPT for Rare Autosomal Aneuploidies and Large Copy Number Variations. Journal of Clinical Medicine. 2022; 11(2):372. doi:10.3390/jcm11020372
5. Yuan X, Yong W, Dai L, Wang W, Wu L. The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton: a retrospective study. Ann Transl Med. 2023 Jan 31;11(2):111. doi: 10.21037/atm-22-6343.
6. Konya M, Czimbalmos A, Loczi L, Koi T, Turan C, Nagy R, Acs N, Hegyi P, Varbiro S, Gal A. Genome-Wide, Non-Invasive Prenatal Testing for rare chromosomal abnormalities: A systematic review and meta-analysis of diagnostic test accuracy. PLoS One. 2024 Nov 5;19(11): e0308008. doi: 10.1371/journal.pone. 0308008.